Intech Investment Management LLC Invests $204,000 in Genpact Limited (NYSE:G)

Intech Investment Management LLC acquired a new position in Genpact Limited (NYSE:G – Get Rating) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 4,409 shares of the business services provider’s stock, valued at approximately $204,000.

Other institutional investors have also made changes to their positions in the company. Ronald Blue Trust Inc. bought a new stake in Genpact during the fourth quarter worth $28,000. Exchange Traded Concepts LLC bought a new stake in Genpact during the fourth quarter worth $30,000. Cullen Frost Bankers Inc. bought a new stake in Genpact during the third quarter worth $39,000. IFP Advisors Inc raised its position in Genpact by 148.5% during the third quarter. IFP Advisors Inc now owns 1,014 shares of the business services provider’s stock worth $44,000 after acquiring an additional 606 shares in the last quarter. Finally, Belpointe Asset Management LLC bought a new stake in Genpact during the fourth quarter worth $52,000. Institutional investors own 95.17% of the company’s stock.

Genpact Stock Performance

Shares of Genpact stock opened at $38.00 on Tuesday. The company has a market capitalization of $7.00 billion, a price-to-earnings ratio of 19.59, a PEG ratio of 1.70 and a beta of 1.20. The company has a quick ratio of 1.84, a current ratio of 1.84 and a debt-to-equity ratio of 0.65. Genpact Limited has a 12-month low of $35.75 and a 12-month high of $48.85. The firm’s 50-day moving average price is $43.06 and its two-hundred day moving average price is $45.14.

Genpact (NYSE:G – Get Rating) last announced its quarterly earnings data on Wednesday, May 10th. The business services provider reported $0.60 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.55 by $0.05. The firm had revenue of $1.09 billion for the quarter, compared to the consensus estimate of $1.10 billion. Genpact had a net margin of 8.27% and a return on equity of 25.74%. On average, analysts forecast that Genpact Limited will post 2.54 earnings per share for the current fiscal year.

Genpact Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, June 26th. Shareholders of record on Friday, June 9th will be paid a dividend of $0.1375 per share. The ex-dividend date of this dividend is Thursday, June 8th. This represents a $0.55 dividend on an annualized basis and a yield of 1.45%. Genpact’s payout ratio is 28.35%.

Insiders Place Their Bets

In related news, Director James C. Madden bought 2,500 shares of the company’s stock in a transaction dated Tuesday, May 16th. The stock was purchased at an average price of $36.86 per share, with a total value of $92,150.00. Following the completion of the acquisition, the director now owns 44,947 shares of the company’s stock, valued at $1,656,746.42. The purchase was disclosed in a document filed with the SEC, which is available through this link. In related news, Director James C. Madden bought 2,500 shares of the company’s stock in a transaction dated Tuesday, May 16th. The stock was purchased at an average price of $36.86 per share, with a total value of $92,150.00. Following the completion of the acquisition, the director now owns 44,947 shares of the company’s stock, valued at $1,656,746.42. The purchase was disclosed in a document filed with the SEC, which is available through this link. Also, CEO N. V. Tyagarajan sold 50,000 shares of the stock in a transaction dated Tuesday, May 16th. The stock was sold at an average price of $36.73, for a total transaction of $1,836,500.00. Following the completion of the transaction, the chief executive officer now directly owns 805,509 shares of the company’s stock, valued at approximately $29,586,345.57. The disclosure for this sale can be found here. Insiders have sold 315,000 shares of company stock worth $13,511,225 over the last ninety days. Corporate insiders own 2.62% of the company’s stock.

Analysts Set New Price Targets

Several research firms have issued reports on G. Citigroup dropped their price target on shares of Genpact from $54.00 to $46.00 in a research report on Thursday, May 11th. StockNews.com started coverage on shares of Genpact in a research report on Thursday, May 18th. They issued a “buy” rating on the stock. Jefferies Financial Group dropped their price objective on shares of Genpact from $47.00 to $41.00 in a research report on Monday, May 15th. Robert W. Baird dropped their price objective on shares of Genpact from $54.00 to $48.00 in a research report on Thursday, May 11th. Finally, BMO Capital Markets increased their price objective on shares of Genpact from $51.00 to $53.00 and gave the company a “market perform” rating in a research report on Wednesday, February 8th. Two analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $49.00.

About Genpact

(Get Rating)

Genpact Ltd. engages in the business process management, outsourcing, shared services and information outsourcing. The company operates through the following segments: Banking, Capital Markets and Insurance (BCMI), Consumer Goods, Retail, Life Sciences, and Healthcare (CGRLH) and High Tech, Manufacturing, and Services (HMS).